Delivery Order SPE2DR25D3015-SPE2DR26F4FM7
- Not listed
- The Defense Logistics Agency awarded a $7,760.84 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector units, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $10,997 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, with an ultimate completion date of September 26, 2025. This delivery order, issued on September 25, 2025, represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $31,539.64 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units. This firm fixed-price delivery order, issued on November 14, 2025, with completion targeted for November 17, 2025, represents a child contract executed under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively issued with no set-aside designation, and...
- The Defense Logistics Agency (DLA) awarded a $16,873.06 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector medication, with a completion date of October 29, 2025. This competitive award uses firm fixed pricing and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of TALTZ 80 mg/ml autoinjectors, valued at $42,488.12. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitively awarded contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. This award represents a...
- The Defense Logistics Agency awarded a $10,932.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of TALTZ 80 mg/ml autoinjectors. This is a firm fixed price, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 7, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,341.02 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/ml autoinjector medication. This firm fixed-price delivery order, issued on December 3, 2025, with completion scheduled for December 4, 2025, represents a child contract under AmerisourceBergen's broader indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and...
- The Defense Logistics Agency awarded a $39,167.67 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FM7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,143.63 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML auto-injectors. This firm fixed-price, non-set-aside contract was executed on December 16, 2025, with an ultimate completion date of December 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order represents a child contract under a larger indefinite delivery contract (IDC) vehicle, leveraging AmerisourceBergen's established pharmaceutical supply relationships with the Defense Logistics Agency. This award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor for federal military and healthcare systems. The company operates under a significant parent IDC with the DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's competitive award history and extensive pharmaceutical product portfolio demonstrate its capability to fulfill specialized federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 12/15/25 |